Roy Male (above), deputy chief executive of Addenbrooke's trust, has been appointed trust chief executive. He is expected to take up his new post in the summer when current chief executive John Ashbourne retires.

Forest Healthcare trust has appointed Beverley Evans as assistant director of finance for acute services, and costing and pricing. She was previously the trust's finance manager for costing and pricing.

Karen Ward, Mount Vernon and Watford Hospitals trust's accident and emergency manager, has been promoted to acting quality director.

Nottingham Healthcare trust has reappointed Alan Aitkenhead and Usha Sood as non-executive directors. Professor Aitkenhead is professor of anaesthesia at Nottingham University, and consultant anaesthetist at the University Hospital and City Hospital trusts. Ms Sood is a senior law lecturer at Nottingham Trent University and a practising barrister.

Derek Calam, European co-ordinator of the National Institute for Biological Standards and Control, has been appointed chair of the British Pharmacopoeia Commission. Four new members have been appointed: Stuart Barton, medical director, National Prescribing Centre; David Begg, pharmaceutical quality assurance manager; Vian Fenton-May of the Welsh Office medical inspectorate; and David Woolfson, professor of the pharmaceutics school of pharmacy, Queen's University, Belfast.

Eight new appointments have been made to the Medicines Commission: Margaret Bassendine, professor of hepatology, Newcastle University; William Bogie, European regional director, Medeva; Peter Cardy, chief executive, Multiple Sclerosis Society and Motor Neurone Disease Association; Joseph Collier, reader and honorary consultant, clinical pharmacology, St George's Hospital, London; Peter Day, Fullerian professor of chemistry, Royal Institute of Great Britain; James Riddell, consultant physician, Queen's University, Belfast; Herbert Sewell, head of immunology, University Hospital Medical School, Nottingham, and Robert Stevenson, senior partner, veterinary centre, Gwent.

Penny Willis, who joined the NHS as a researcher in 1983 and was a former corporate development director at Homewood trust, has died after battling against ovarian cancer.